Skip to main content
Premium Trial:

Request an Annual Quote

MWG Biotech to Exit Microarray and Lab Automation Businesses

This article has been updated from an earlier version.

NEW YORK, Oct. 8 (GenomeWeb News) - Ebersberg, Germany-based MWG Biotech today said that it plans to divest its microarray and lab automation businesses.

In a statement, the company said that managment will consider "various separation" options for the divestiture of the product lines to focus on its genomic synthesis business, the production of synthetic nucleic acids and oligonucleotides, and genomic information (DNA sequencing).

The company said it expects a negative impact on its financials, but was not able to provide any specific guidance, but said it will seek new capital.

MWG was founded in 1990 and added its genomic diagnostics (microarrays) division in 2000.



The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.